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IN TRO DUC TION
Hu man papilloma vi rus (HPV) has been as so ci -
ated with sev eral types of be nign and ma lig nant le -
sions of both skin and mu cous mem branes. In the
gen i tal area, HPV in fec tion may cause the de vel op -
ment of condyloma acuminatum (gen i tal wart),
bowenoid papulosis, or squamous cell car ci noma
(SCC) (1). In men, some types of HPV have been
im plied as pos si ble agents that trig ger the in duc tion
of dysplasia, anal and penile car ci noma. Most
cases of condylomata acuminata in the male
anogenital tract con tain HPV types 6 and 11, of “low
ma lig nity risk”, while pre-ma lig nant le sions or in va -
sive tu mors fre quently con tain HPV types 16 and
18, which are of “high malignity risk” (2).
Bowenoid papulosis pres ents, in most cases,
with pig mented papules in the gen i ta lia. It has been
as so ci ated with HPV in fec tion in volv ing vi rus types
16, 18, 31-34, 39, 42, 48, and 51-54, with HPV 16
be ing more com mon than other types. Histopatho -
logi cally, it pro duces an SCC in situ pic ture, with vi -
ral cytopathic al ter ations. Its evo lu tion is nor mally
be nign, but may prog ress to in va sive SCC, mainly
in immunodepressed pa tients, who also have a dif -
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fi cult re sponse to con ven tional treat ments and
greater number of recurrences (3-7).
Imiquimod is an immunomodulator with an ti vi ral
and in di rect antitumor ac tiv i ties. It acts by cytokine
in duc tion, pri mar ily in ter feron-a, re sult ing in an in -
crease of im mune re sponse through cell me di a tion
(6,8). In this way, be sides de stroy ing vis i ble le sions, 
it com bats the la tent in fec tion, re duc ing the number
of recurrences (7).
CASE RE PORT
A 53-year-old black man, pre vi ously treated for
syph i lis and known to be HIV-pos i tive for seven
years, pre sented with asymp tom atic gen i tal le sions
that de vel oped over 18 months. He had sys temic
ar te rial hy per ten sion con trolled with atenolol, asym -
p to m atic hep a ti tis C, and was hos pi tal ized for dys -
pha gia, fe ver, and post pran dial vom it ing. Di ges tive
en dos copy re vealed esophagitis caused by her pes
sim plex vi rus (HSV), with as so ci ated candidiasis.
The pa tient stated that he used il licit drugs (in haled
co caine) and had had mul ti ple sex ual part ners of
both sexes in the last sev eral years. A dermato lo -
gical con sul ta tion was re quested for eval u a tion of
the gen i tal le sions.
At phys i cal ex am i na tion, the pa tient pre sented
with a good gen eral con di tion. A hyperchromic ma -
cu lo papular le sion was found in the balano preputial 
groove (Fig. 1), whereas gray ish, flat, con flu ent
pap u lar veg e tat ing le sions were lo cated on the dor -
sum of the pe nis and scro tum (Fig. 2). There was
also an exulcerated and pain ful le sion on the glans
com pat i ble with ul cer caused by HSV, which im -
proved with parenteral acyclovir ad min is tered for
the treat ment of the esophagitis.
Due to the clin i cal sus pi cion of in fec tion with
HPV, bi op sies of le sions on the glans and dor sum of 
the pe nis were per formed. Histopathological ex am i -
na tion of bi opsy ma te rial re vealed vacuolation of
the keratinocytes and nu clear hyperchromasia;
acanthosis with papillomatosis, pigmentary in con ti -
nence, and mel a nin in the up per lay ers of the epi -
der mis; hy per pla sia of the keratinocytes at the base 
of the le sion with dis or dered ep i the lial ar chi tec ture,
nu clear pil ing up, and mild atypia. Such histological
al ter ations were com pat i ble with bo we no id papu -
losis. The poly mer ase chain re ac tion to de tect the
pres ence of HPV types 6-11 and 16-18 revealed
HPV 16 in both lesions.
The im mu no log i cal pro file, per formed only three
months af ter the first dermatological con sul ta tion
(when the pa tient had al ready been us ing reg u lar
anti-retroviral ther apy), showed a vi ral load of less
than 80 cop ies/mL and a CD4 T-lym pho cyte count
of 198 cells/mm3.
The pa tient was in structed to ap ply imiquimod
5% cream on the le sions three times a week, leav -
ing it over night for eight hours. He com pleted 16
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Fig ure 1. Bowenoid le sions in the balanopreputial groove.
Fig ure 2. Le sions on the dor sum of the pe nis and scro -
tum.
weeks of treat ment with out any side ef fect. Af ter 12
weeks of ther apy, there was al ready a com plete re -
gres sion of the le sion in the balanopreputial area
and par tial re gres sion of the le sions on the pe nis. At 
the end of the 16 weeks, only about six pap u lar re -
sid ual le sions re mained on the dor sum of the pe nis
(Fig. 3 and 4). The treat ment was com ple mented
with com bined chem i cal cau ter i za tion by use of
50% trichloroacetic acid, fol lowed by ap pli ca tion of
25% podophylin ev ery three weeks. The pa tient
also ap plied imiquimod 5% cream on le sions of mo -
l lus cum contagiosum in the beard area, with com -
plete re gres sion af ter four weeks. Antiretroviral
treat ment was started con com i tantly with 600 mg/
day of zi dovu dine, lamivudine 300 mg/day, and
nevirapine 400 mg/day.
DIS CUS SION
Immunodepressed pa tients rep re sent a dis tinct
group among pa tients with HPV in fec tions. They
are fre quently in fected with types of high risk HPV,
usu ally un com mon in immunocompetent pa tients,
and are prone to more ag gres sive forms of dis ease, 
with greater in ci dence of oncogenic trans for ma tion
(2). HIV in fec tion can also pro mote the per sis tence
or re ac ti va tion of the HPV in the gen i tal tract, fa vor -
ing its pro gres sion to can cer be sides fa cil i tat ing the
pri mary HPV in fec tion (1). There fore, as in our pa -
tient, immunodepressed pa tients with high risk HPV 
le sions that al ready show intraepithelial neo plas tic
changes should have their treat ment op ti mized to
avoid the development of invasive disease.
There are sev eral treat ment mo dal i ties for the
le sions caused by HPV, in clud ing top i cal ap pli ca -
tion of chemotherapeutic agents, such as podophi -
lo toxin, 5-fluouracil 5%, and etretinate; chem i cal
cau ter i za tion with 30% or 50% trichloroacetic acid
and 25% podophylin; and sur gi cal ex tir pa tion by
electrocoagulation, cryosurgery, sur gi cal re moval
or Mohs’ micrographic sur gery (6). How ever, these
mo dal i ties only de stroy the le sion, whereas the vi -
rus re mains in la tency in the sur round ing cells,
caus ing fre quent re cur rences. Immunomodulatory
treat ment is the only that can de stroy the vi rus,
imiquimod 5% cream be ing one of the cur rent ther -
a peu tic op tions. Re cent re ports of its use in the
treat ment of mollusca contagiosa, vi ral cu ta ne ous
in fec tions as so ci ated with HIV, and recalcitrant
facial warts are promising (9-11).
How ever, tra di tion ally ef fec tive treat ments for
HPV in fec tions in immunocompetent pa tients are
fre quently less ef fec tive in immunocompromized in -
di vid u als. A study by Gilson et al (12) dem on strated
that the cream with imiquimod was not sig nif i cantly
better than pla cebo in ob tain ing a com plete re -
sponse in HIV-pos i tive pa tients, but it caused a sig -
nif i cant de crease in the area at tacked by the warts,
al low ing the com bined treat ment with other med i ca -
tions. The same re sults were ob tained in our pa -
tient, with al most com plete re gres sion of the le sions 
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Fig ure 4. Dor sum of the pe nis and scro tum af ter 16
weeks of treat ment with imiquimod.
Fig ure 3. Balanopreputial groove af ter 16 weeks of treat -
ment with imiquimod.
af ter the use of cream with imiquimod, mak ing the
end of the treat ment with chem i cal cau ter i za tion vi -
a ble. Godfrey et al (13), on the other hand, re ported
on a case of a nine-year-old HIV-pos i tive girl with
bowenoid papulosis, who showed lit tle re sponse to
the use of the cream ap plied ev ery other day for two 
months. A monthly chem i cal cau ter i za tion with 25%
podophylin was then started with com plete re gres -
sion of the le sions af ter one year (13).
Our pa tient’s im prove ment could be ques tioned
re gard ing its re la tion ship with the be gin ning of the
antiretroviral ther apy, which co in cided with the be -
gin ning of the use of the imiquimod 5% cream.
How ever, af ter three months of the spe cific treat -
ment, the pa tient still had a CD4 count be low 200
cells/mm3. In any way, one can not avoid con sid er -
ing that a global im prove ment of the pa tient’s im mu -
no log i cal sta tus could have con trib uted to the
therapeutic success.
CON CLU SION
The imiquimod 5% cream was an ex cel lent op -
tion in the treat ment of the le sions of bowenoid
papulosis in our pa tient with AIDS re gard less of his
low CD4 count, al low ing complementation of the
treat ment with chem i cal cau ter i za tion. The re gres -
sion of the le sions of mollusca contagiosa on the
pa tient’s face was also ob tained. The treat ment
was prac ti cal (could be per formed at home) and
there were no side effects.
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